Conquering Diseases

20 Studies found

Chronic Pancreatitis

Digestive and Liver Diseases

Digestive and Liver Diseases

Gender

Male/Female

Age

All

Compensation

None

Image of Krunal Patel

Digestive and Liver Diseases

Gender

Male/Female

Age

Adult

Compensation

None

Image of Deepika Devuni

Digestive and Liver Diseases

Gender

Male/Female

Age

65 and older

Compensation

Offered

Image of John Haran

Digestive and Liver Diseases

Laser Fistula Study

Seeking Men and Women 18-65 years old who have a fistula-in-ano that needs treatment.

Digestive and Liver Diseases

Digestive and Liver Diseases

Gender

Male/Female

Age

Adult

Compensation

None

Image of David Cave

Digestive and Liver Diseases

Alcoholic Hepatitis Network Observational Study

Seeking healthy volunteers who either drink less than 1 drink per week on average or at least 3 drinks per day for a study collecting biological samples (blood, urine, and stool) and health information to better understand alcoholic hepatitis.

Healthy Volunteers Wanted.

Digestive and Liver Diseases

Digestive and Liver Diseases

Gender

Male/Female

Age

Adult

Compensation

Offered

Image of David Cave

Inflammation of Esophagus

Gender

Male/Female

Age

12 and older

Compensation

Offered

Image of David Cave

Inflammatory Bowel Disease

Gender

Male/Female

Age

Adult

Compensation

Offered

Image of David Cave

Inflammatory Bowel Disease

Gender

Male/Female

Age

Adult

Compensation

Offered

Image of David Cave

Inflammatory Bowel Disease

Gender

Male/Female

Age

Adult

Compensation

Offered

Image of David Cave

Liver Cancer

Nonalcoholic Steatohepatitis

Aurora: A Study Of An Experimental Drug For Liver Scarring Caused By Nash

Nonalcoholic Steatohepatitis (NASH) is a disease that results when fat accumulates in the liver and eventually causes inflammation and scarring called fibrosis. The purpose of this study is to test whether an experimental drug, CVC, is safe and effective in treating advanced scarring of the liver due to NASH.

Gender

Male/Female

Age

18+

Compensation

Offered

Image of Curtis Barry

Nonalcoholic Steatohepatitis

Reverse: A Study Of An Investigational Drug For Compensated Cirrhosis Due To Nonalcoholic Steatohepatitis (Nash)

Nonalcoholic Steatohepatitis (NASH) results when fat accumulates in the liver and causes inflammation and scarring called fibrosis. Fibrosis can lead to cirrhosis which impairs liver function. Ocaliva (OCA) is an FDA approved drug for treating another type of liver disease. This study will test if Ocaliva (OCA) is safe and effective in treating cirrhosis of the liver caused by advanced NASH.

Rectal Cancer

Rectal Cancer

Rectal Cancer Surgery Research

Seeking adults with rectal cancer requiring surgery for a study comparing an investigational surgery to the standard surgery technique